Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: United Kingdom Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20033
20042
20051
20068
20072
20081
20096
20106
20119
20126
20135
20147
20153
20164
20192
20203
20213
20224
20234
20242
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed73
Recruiting8
Terminated4
Unknown status4
Active, not recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca21
GlaxoSmithKline14
Boehringer Ingelheim12
Novartis Pharmaceuticals10
Sanofi7
Chiesi Farmaceutici S.p.A.4
Imperial College London3
Pearl Therapeutics, Inc.3
Hoffmann-La Roche2
Mundipharma Research Limited2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive93
Bronchitis, Chronic4
Emphysema3
Lung Diseases3
Lung Diseases, Obstructive3
Asthma2
Bronchiolitis Obliterans Syndrome2
Dyspnea2
Heart Failure2
Respiratory Tract Diseases2

Trials

Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.